BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

HemoShear, LLC Hires Industry Business Development Veteran Vincent Aurentz as Chief Business Officer


8/6/2013 8:06:55 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHARLOTTESVILLE, Va., Aug. 6, 2013 /PRNewswire/ -- HemoShear, LLC, a leading developer of human-relevant systems for drug discovery and development, today announced that Vincent Aurentz has joined HemoShear as the Company's Chief Business Officer. Mr. Aurentz is widely respected in the pharmaceutical industry and brings to HemoShear a very strong combination of executive management experience in pharmaceutical R&D, licensing and business development, as well as expertise in building strategic partnerships.

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO)

Mr. Aurentz has worked for over 24 years in life sciences. Most recently, he was Executive Vice President of the Customer Solutions Business at Quintiles where he created a new business model to engage their customers. Previously, he spent almost nine years with Merck KGaA where he served as Executive Vice President, Portfolio Development, for Merck Serono and was a member of the Executive Management Board. He was responsible for Licensing and Business Development, Global Product leadership for the R&D pipeline, and Portfolio Management. Prior to his role at Merck Serono, he was Merck KGaA's Global Head of Licensing and Business Development. Mr. Aurentz is formerly a co-founder and Managing Director of True North Partners, a venture capital and advisory business focused on the healthcare industry. He was also a partner for CSC Healthcare in New York and worked at Andersen Consulting (now known as Accenture).

"I am excited to join HemoShear's talented organization," said Mr. Aurentz. "I was struck by the quality of the science that HemoShear has developed, its potential to improve the productivity of drug R&D, and their vision for broad partnerships with pharma. In considering the opportunity to join HemoShear, I spoke with several executives in pharma who shared a consistent message regarding the value of HemoShear's science in understanding human biology and response to new drug candidates at a level that has not existed before."

"Vince is an outstanding addition to HemoShear's executive team. As we grow, we want to recruit the best people in the industry to drive our business," said James Powers, HemoShear's CEO. "Vince's expertise will help us unlock the immense value that our enabling science brings to our pharmaceutical partners' drug R&D programs."

About HemoShear, LLC

By applying physiologically accurate hemodynamics and biological transport to primary cell cultures, HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases for applications throughout drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies. HemoShear's science leads to new medicines and improves human health.

For information about HemoShear, please visit www.hemoshear.com.

SOURCE HemoShear, LLC



Hey, check out all the research scientist jobs. Post your resume today!


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES